Certara (NASDAQ: CERT)
Certara Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Certara Company Info
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Princeton, NJ.
News & Analysis
Certara (CERT) Q2 Revenue Jumps 12%
Why Certara's Shares Rose 37.7% This Week
The company, which helps other companies in their drug development, reported strong third-quarter numbers.
Valuation
Earnings Transcripts
Certara, Inc. (CERT) Q2 2022 Earnings Call Transcript
CERT earnings call for the period ending June 30, 2022.
Certara, Inc. (CERT) Q1 2022 Earnings Call Transcript
CERT earnings call for the period ending March 31, 2022.
Certara, Inc. (CERT) Q4 2021 Earnings Call Transcript
CERT earnings call for the period ending December 31, 2021.
Certara, Inc. (CERT) Q3 2021 Earnings Call Transcript
CERT earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.